Ashmit Gupta, MD
Otolaryngology · Voorhees, NJNPI 1245220151
Payments from drug & device makers
Across 65 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$301
- Optinose US, Inc.$236
- Sanofi$234
- Medtronic$119
- Alk-abello, Inc$77
- Regeneron Healthcare Solutions, Inc.$73
- plus $145 from 6 others
What the payments were for
- Food & beverage$1,186100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $301 |
| Optinose US, Inc. | 16 | $236 |
| Sanofi | 12 | $234 |
| Medtronic(2 entities) | 2 | $119 |
| Alk-abello, Inc | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| Stryker | 2 | $42 |
| Grifols USA, LLC | 2 | $33 |
| Merck | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
| Boston Scientific | 1 | $12 |
How this compares
$1,186 in reported general payments places this provider in the 45th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 19 | $7,830 |
| Famotidine | 527 | $6,027 |
| Ipratropium Bromide | 95 | $3,878 |
| Montelukast Sodium | 224 | $2,803 |
| Omeprazole | 148 | $1,971 |
| Azelastine Hcl | 71 | $1,911 |
| Cefdinir | 75 | $1,473 |
| Fluticasone Propionate | 69 | $1,144 |
| Mometasone Furoate | 73 | $1,074 |
| Methylprednisolone | 180 | $950 |
| Ofloxacin | 27 | $807 |
| Azithromycin | 116 | $672 |
| Desloratadine | 12 | $519 |
| Moxifloxacin Hcl | 13 | $489 |
| Pantoprazole Sodium | 37 | $471 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Voorhees
- Samir ShahVoorhees$16K
- Kartik DanduVoorhees$4K
- Luke KimVoorhees$4K
- Mark FriedelVoorhees$3K
- Nishant ReddyEast Windsor$133K
- Justin McCormickNew Brunswick$109K
- Andrew BlitzerHackensack$40K
- Rakesh PatelParamus$26K
- Giant LinFlorham Park$25K
- Jeffrey AroestyMount Arlington$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.